Education
About Us
Working with TipRanks
Follow Us
Oncolys BioPharma, Inc. (JP:4588)
:4588
4588 Stock Chart & Stats
¥1061.00
-¥1.00(-0.20%)
At close: 4:00 PM EST
¥1061.00
-¥1.00(-0.20%)
Day’s Range― - ―
52-Week Range¥458.00 - ¥1,197.00
Previous CloseN/A
Volume332.10K
Average Volume (3M)1.52M
Market Cap
¥26.38B
Enterprise Value¥15.23B
Total Cash (Recent Filing)¥1.39B
Total Debt (Recent Filing)¥377.04M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Feb 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-11.78
Shares Outstanding28,621,100
10 Day Avg. Volume2,742,450
30 Day Avg. Volume1,517,566
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)4.11
Price to Sales (P/S)360.33
P/FCF Ratio-5.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Oncolys BioPharma, Inc. News
4588 FAQ
What was Oncolys BioPharma, Inc.’s price range in the past 12 months?
Oncolys BioPharma, Inc. lowest stock price was ¥458.00 and its highest was ¥1197.00 in the past 12 months.
What is Oncolys BioPharma, Inc.’s market cap?
Oncolys BioPharma, Inc.’s market cap is ¥26.38B.
When is Oncolys BioPharma, Inc.’s upcoming earnings report date?
Oncolys BioPharma, Inc.’s upcoming earnings report date is Feb 06, 2026 which is in 53 days.
How were Oncolys BioPharma, Inc.’s earnings last quarter?
Oncolys BioPharma, Inc. released its earnings results on Nov 07, 2025. The company reported -¥11.78 earnings per share for the quarter, missing the consensus estimate of N/A by -¥11.78.
Is Oncolys BioPharma, Inc. overvalued?
According to Wall Street analysts Oncolys BioPharma, Inc.’s price is currently Overvalued.
Does Oncolys BioPharma, Inc. pay dividends?
Oncolys BioPharma, Inc. does not currently pay dividends.
What is Oncolys BioPharma, Inc.’s EPS estimate?
Oncolys BioPharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncolys BioPharma, Inc. have?
Oncolys BioPharma, Inc. has 28,621,100 shares outstanding.
What happened to Oncolys BioPharma, Inc.’s price movement after its last earnings report?
Oncolys BioPharma, Inc. reported an EPS of -¥11.78 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.907%.
Which hedge fund is a major shareholder of Oncolys BioPharma, Inc.?
Currently, no hedge funds are holding shares in JP:4588
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Oncolys BioPharma, Inc.
Oncolys BioPharma, Inc. (4588) is a biotechnology company focused on developing innovative therapies for cancer treatment. The company is engaged in the research, development, and commercialization of biopharmaceuticals that harness the immune system to combat various types of tumors. Its core products include novel cancer therapies, particularly in the areas of immuno-oncology and targeted therapies, aimed at improving efficacy and safety for patients with cancer.
Technical Analysis
RaQualia Pharma Inc.
―
Chiome Bioscience Inc.
―
StemRIM Inc.
―
CellSource Co., Ltd.
―
STELLA PHARMA CORPORATION
―